Inquiries & Help
When the COVID-19 pandemic plunged the world into a state of emergency in 2020, one key question suddenly arose: How can millions of vaccine doses be transported safely and reliably around the globe? The answer lay—at least in part—in a material that had been part of ASCO's everyday business for decades: dry ice.
From one day to the next, the global demand for dry ice rose rapidly. Dry ice became an indispensable part of global vaccine logistics, especially for the transport of sensitive vaccines that had to be stored at temperatures as low as –80 °C. ASCO responded immediately.
Within a very short time, the company developed new filling and transfer systems that automated the filling of shipping boxes with dry ice, thereby significantly speeding up the process. These systems made it possible to dispense freshly produced dry ice directly into the transport containers – a milestone that not only brought efficiency but also helped to meet the strict cold chain requirements worldwide.
At the same time, ASCO ensured the delivery capability of its machines and systems during this challenging period. Despite interrupted supply chains, closed borders, and enormous demand, the company remained operational – thanks to a well-coordinated team, a high level of in-house production, and close cooperation with customers around the world.
During the pandemic, ASCO became a quiet but crucial player in the global fight against COVID-19 – with innovative solutions that helped get vaccines safely to their destination. A chapter that impressively demonstrates how CO₂ technology can save lives.
